NEMISE Registry

SSTR-PET imaging findings classified by NEMISE may be linked to NET patient outcomes. To deepen our understanding of the relationship between PET findings and patient survival, we have established an international registry study.

This registry invites imaging sites worldwide that utilize SSTR-PET for a range of different neuroendocrine tumor entities and stages and that hold data on patient overall survival. Centers are encouraged to contribute SSTR-PET findings to our collective knowledge base.